苦黄注射液用于病毒性肝炎的网状Meta分析及药物经济学评价  

Network Meta-Analysis and Pharmacoeconomic Evaluation of Kuhuang Injection for Viral Hepatitis

作　　者：周瑞月 陈旭[2] 董兰东 ZHOU Ruiyue;CHEN Xu;DONG Landong(Dept.of Hepatology,Shanxi Provincial Hospital of Traditional Chinese Medicine,Taiyuan 030012,China;Dept.of Pulmonary Disease,Shanxi Provincial Hospital of Traditional Chinese Medicine,Taiyuan 030012,China;Clinical College of Traditional Chinese Medicine,Shanxi University of Traditional Chinese Medicine,Taiyuan 030002,China)

机构地区：[1]山西省中医院肝病科,太原030012 [2]山西省中医院肺病科,太原030012 [3]山西中医药大学中医临床学院,太原030002

出　　处：《中国医院用药评价与分析》2023年第7期864-867,共4页Evaluation and Analysis of Drug-use in Hospitals of China

基　　金：山西省卫生健康科研课题(No.2019067)。

摘　　要：目的:评价苦黄注射液用于病毒性肝炎湿热内蕴证的有效性、经济性。方法:数据库检索苦黄注射液与舒肝宁注射液治疗病毒性肝炎的临床研究,通过网状Meta分析方法评估两者的临床疗效,并通过最小成本法评价两者的经济性。结果:本研究共纳入文献22篇。网状Meta分析结果发现,苦黄注射液与舒肝宁注射液的疗效基本一致。最小成本法结果表明,苦黄注射液的日用药费用(42.52元)低于舒肝宁注射液(323.80元)。结论:苦黄注射液用于病毒性肝炎湿热内蕴证的疗效与舒肝宁注射液基本一致,而成本低于舒肝宁注射液,具有经济学优势。OBJECTIVE:To evaluate the efficacy and economy of Kuhuang injection for viral hepatitis with damp heat syndrome.METHODS:The database was retrieved for the clinical research of Kuhuang injection and Shuganning injection in the treatment of viral hepatitis,the clinical efficacy was evaluated by the network Meta-analysis method,and the economical efficiency was evaluated by the minimum cost method.RESULTS:A total of 22 articles were included in this study.Network Meta-analysis showed that the efficacy of Kuhuang injection and Shuganning injection were basically the same.Results of the minimum cost method showed that the daily drug cost of Kuhuang injection(42.52 yuan)was lower than that of Shuganning injection(323.80 yuan).CONCLUSIONS:The efficacy of Kuhuang injection for viral hepatitis with damp heat syndrome is basically the same as Shuganning injection,yet the cost is lower than Shuganning injection,which has economic advantages.

关 键 词：苦黄注射液 病毒性肝炎 药物经济学评价 网状Meta分析 

分 类 号：R932[医药卫生—生药学]